CMRO Mission Statement
Current Medical Research & Opinion's mission is to validate high quality articles through rigorous peer review, and to be a leader in transparency by facilitating a collaborative and honest approach to publication.
Aims and Scope
Current Medical Research & Opinion aims to bridge the gap between industry breakthrough and point of care by providing physicians and other healthcare professionals with therapeutically innovative and clinically relevant information that has the potential to inform and impact medical practice. We welcome the following contributions:
- Full-length articles reporting the original results of Phase II–IV studies and post-marketing investigations. Equiva-lence, safety and efficacy/effectiveness studies are encouraged.
- Information on pharmaceutical preparations and medical devices, including therapeutic diagnostic (theranostic) products and over-the-counter medicines, as well as ethical pharmaceutical products and prescription-only medicines.
- Review articles on new and existing drugs; drug classes and therapeutic areas; and disease states.
- Brief Reports, Commentaries and Research Letters that meet the above criteria, and Letters to the Editor briefly commenting on work previously published in the journal. (A full description of types of article is included on page VIII of the CMRO Notes for Contributors PDF document.)
Supplements are also published and encouraged. These include both stand-alone and in-journal supplements based on symposia proceedings (sponsored workshops, meetings, webinars, webcasts, etc.), or collected articles on specific drugs or disease states. Enquiries from potential guest editors, meeting organizers and sponsors are welcomed. Supplements undergo the same rigorous peer review used for regular CMRO articles, and must adhere to CMRO's transparency policy and acknowledgments requirements.
Online and Print Publication
CMRO is published continuously online. All articles are first published online on the CMRO EarlyOnline platform, followed by print and electronic publication in one of the 12 published issues per year. EarlyOnline articles have final pagination as well as DOI information, are immediately citable and are made available as Epub ahead of print entries on PubMed. Articles appear in print and electronic issues 2-6 weeks later from Early Online publication. Articles published in the electronic issues are available in xml full text, PDF or PDF Plus (with CrossRef citation linking).
Indexing
Indexed / abstracted in MEDLINE / PubMed and EMBASE / Excerpta Medica, Current Contents / Clinical Medicine, Science Citation Index and ISI Web Of Knowledge and in the following databases: Adis Clinical Trials Insight, CA Search/CAS Online, CAB Abstracts, CancerLit, Derwent Drug File, HEED/Health Economic Evaluations Database, International Pharmaceutical Abstracts, NLM Gateway, Pascal, Pharm-line, PsycINFO, SciSearch, Science Citation Index Expanded (Web of Science), SIIC and TOXFILE/Toxline.
Publication Impact Factors
5-Year ISI Impact Factor (2009): 2.697
1-Year ISI Impact Factor (2009): 2.498
CMRO is ranked 26/132 in the Medicine, General & Internal category in the 2009 ISI Journal Citation Reports.
Publication Information
- Founded in 1972
- ISSN: Online eISSN: 1473-4877
- Print Frequency: 12 issues per year plus supplements
Editorial Contacts
For all general editorial and submission enquiries please email: info@cmrojournal.com or refer to the latest Notes for Contributors
Publisher: Malavika Legge (malavika.legge@informa.com)
Managing Editor: Terri Metules (tmetules@cmrojournal.com)
Editorial Assistant: Janise Lazarte (janise.lazarte@informa.com)
Editorial Advisory Boards
Overseeing the editorial content and development of the journal are Editorial Boards of international leading experts in clinical research and pharmaceutical medicine.
For information about the Editorial Board please click here.
Policies
Transparency Policy
CMRO supports and follows the various good publishing practice guidelines and initiatives promulgated by such organizations as ICMJE, ISMPP, COPE, NLM and others that encourage transparency/disclosure of financial relationships with industry. CMRO is a member of COPE.
In an effort to provide transparency beyond those recommended by the aforementioned organizations, CMRO will ensure that any person in a position to influence the content of the journal provides a formal statement of relevant financial or other relationships with commercial entities and may lead to a real or perceived conflict of interest. These financial relationships shall be disclosed to CMRO's readers in print and/or on the CMRO web site.
The full transparency policy is available here >>
Plagiarism
CMRO has a strict policy against plagiarism. We define plagiarism as the use of extracts from another person's work that are not placed in quotation marks, without the permission of that person, and without acknowledgement to that person (using the appropriate reference style), with the result that your article presents these extracts as original to you. By submitting your work to an Informa journal, you warrant that it is your original work, and that you have secured the necessary written permission from the appropriate copyright owner or authority for the reproduction of any text, illustration, or other material.
If any article submitted to CMRO is found to have breached any of these conditions, CMRO reserves the right to reject that article and any others submitted by the same authors. CMRO may also contact the authors' affiliated institutions to inform them of its findings.
Reprints and Post-publication Services
Reprints are available both in print and electronically, in US and European formats and with or without covers. Contact Toby Harrison (toby.harrison@informa.com) for further details.
Printed
- Without covers
The first page of text of the paper is the first page of the reprint. - Cover Options
Self covers (Black & White title page) - Our standard cover design is printed in black and white on the same type of paper as the reprint.
In cases where there are two or more blank pages available there may be no extra charge for this. - Color covers
Our standard color cover design in two colours is printed on heavier weight paper and bound to the reprint.
Formats
There is a choice of 8.5 x 11 inch or A4 format.
For reprints produced in the USA for delivery in the Americas, 8.5 x 11 inch is the usual format.
For reprints produced elsewhere, A4 is the usual format.
Electronic Options
Customised online ePrint service We can host a PDF file of a reprint on our server and provide a secure link to it from another website. Page views are bought in advance and can be renewed. Please contact us for further details.
Licensed PDFs subject to agreement: we can provide a PDF file of a reprint for use on CDs and other media.
Additional Services and Special Requirements
- Customized information, subject to approval.
- Examples include:
- Disclaimers, Product and Regulatory Information
- Codes
- Logos
Subject to the space available these can be printed in black or the same color as the color covers.
Advertisements are subject to copy approval and may incur an additional cost.
Translations
We can have papers translated into almost any other language and reprinted as detailed above.
Obtaining a Quotation
We will normally provide you with a quotation within 1 working day of the request. To help us expediate your request, please provide us with the following information:
- Your full company address
- The full citation - journal, volume, page numbers, title, author
- The quantities you require us to quote for, with or without covers and any format requirements (see above)
- Where you want the reprints shipped
- Any other special requirements, such as codes and disclaimers
You can apply for a reprint quotation here
Supplements
CMRO is amenable to the publication of supplements with the journal. These can include conference reports, proceedings of meetings, workshops, webcasts, and single drug and therapeutic reviews. All supplements are published through our RapidTrack service, which provides for online publication in 10-12 weeks from formal submission; supplements can be made available with free online access for various periods of time, subject to an agreed fee. Supplements can be mailed externally with an issue of CMRO (via polybags), as an in-journal supplement that is contained within the journal itself, or as an online copy. Additional distribution formats and services are offered. To help ensure that supplements are free from promotion, all supplement content undergoes CMRO's standard, rigorous peer-review process.
For supplement quotations or questions, please contact Malavika Legge at malavika.legge@informa.com
Permissions
Material published by CMRO is protected under international copyright law.
Written authorization is required to reproduce any of our material. For non-commercial /scholarly reproduction of small amounts of material such as figures and tables we normally do not charge a fee but written permission is still necessary from us. For commercial requests, a permission fee payment may be necessary. Please be advised that we may not be the copyright holder of the material you wish to use, even if the work was published by us.
Check the original source of the material carefully in the references.
When placing your request with us, ideally by email, please include the following information:
- The full reference of the article from which the material will be taken
- Exactly what material you wish to use and what the use is, including approximate distribution quantities
- What the territories for distribution of the material are
CMRO publications are registered with the Copyright Licensing Agency in the UK and the Copyright Clearance Center in the USA for the limited copying of material for personal, classroom, academic and commercial purposes.
Futher information on permissions requests can be found here.
Subscriptions
Click here for subscription rates to CMRO and other Informa Pharmaceutical Science Journals.
Futher information about subscriptionscan be found here.
Or contact Scott Magrowski at scott.magrowski@informa.com
